Clinical Biochemical Genetics · Indianapolis, IN
NPI
1225476930
Since 2013
Specialty
Clinical Biochemical Genetics
Code 207SG0202X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1002 Wishard Blvd
Indianapolis, IN, 46202
Phone (317) 944-3966
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,622
15 services
Medicare patients, 2023
12
Average age 48
Drug cost, 2024
$1.3M
59 prescriptions
Company payments, 2025
$418
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Molly A McPheron prescribed most often to Medicare patients was Galafold (Migalastat Hcl), with 26 prescriptions and refills. In total Molly A McPheron wrote 59 Medicare prescriptions that cost $1.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Galafold Migalastat Hcl | 26 | 26 | Under 11 | $793K |
| Palynziq Pegvaliase-Pqpz | 14 | 14 | Under 11 | $450K |
Brand drugs: 50 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Molly A McPheron $418 ($418 in general payments such as food, travel and fees) from 4 companies. The largest payer was Genzyme Corporation with $273.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.